Search research articles
Contact Us
Filters
Showing results (61-70 of 284) with videos related to
Page
of 29
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1984
Clonal evolution in the pathogenesis of pancytopenia
J L Abkowitz, J W Adamson
Surgery
|
January 1, 1994
Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment
J W Adamson, J L Spivak
The Keio Journal of Medicine
|
February 24, 2001
Placental/umbilical cord blood (PCB) stem cells for transplantation: early clinical outcomes and the status of ex vivo expansion strategies
A von Drygalski, J W Adamson
The New England Journal of Medicine
|
August 27, 1998
Erythropoietin for end-stage renal disease
J W Adamson, J W Eschbach
Nature
|
March 29, 1974
Method for relating the structure and properties of chemical compounds
G W Adamson, J A Bush
Journal of Mathematical Biology
|
January 23, 2014
Defining and detecting structural sensitivity in biological models: developing a new framework
M W Adamson, A Yu Morozov
The Journal of Clinical Investigation
|
July 1, 1977
Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation
J E Brown, J W Adamson
Blood
|
January 1, 1975
The anemia of chronic disorders: studies of marrow regulation and iron metabolism
S W Douglas, J W Adamson
Scientific Reports
|
October 10, 2020
Identifying the sources of structural sensitivity in partially specified biological models
Matthew W Adamson, Andrew Yu Morozov
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 1, 1989
Guidelines for recombinant human erythropoietin therapy
J W Eschbach, J W Adamson
Page
of 29
Search research articles
Search
Showing results (61-70 of 284) with videos related to
Sort By:
Page
of 29
Progress in Clinical and Biological Research
|
January 1, 1984
Clonal evolution in the pathogenesis of pancytopenia
J L Abkowitz, J W Adamson
Surgery
|
January 1, 1994
Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment
J W Adamson, J L Spivak
The Keio Journal of Medicine
|
February 24, 2001
Placental/umbilical cord blood (PCB) stem cells for transplantation: early clinical outcomes and the status of ex vivo expansion strategies
A von Drygalski, J W Adamson
The New England Journal of Medicine
|
August 27, 1998
Erythropoietin for end-stage renal disease
J W Adamson, J W Eschbach
Nature
|
March 29, 1974
Method for relating the structure and properties of chemical compounds
G W Adamson, J A Bush
Journal of Mathematical Biology
|
January 23, 2014
Defining and detecting structural sensitivity in biological models: developing a new framework
M W Adamson, A Yu Morozov
The Journal of Clinical Investigation
|
July 1, 1977
Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation
J E Brown, J W Adamson
Blood
|
January 1, 1975
The anemia of chronic disorders: studies of marrow regulation and iron metabolism
S W Douglas, J W Adamson
Scientific Reports
|
October 10, 2020
Identifying the sources of structural sensitivity in partially specified biological models
Matthew W Adamson, Andrew Yu Morozov
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 1, 1989
Guidelines for recombinant human erythropoietin therapy
J W Eschbach, J W Adamson
Page
of 29